Bio-Rad Labs (BIO) Q4 Revs Beat Views
Tweet
Share
E-mail
Get Alerts BIO Hot Sheet
Price: $376.41 -1.57%
Revenue Growth %: -0.4%
Financial Fact:
Foreign exchange losses, net: 1.24M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: -0.4%
Financial Fact:
Foreign exchange losses, net: 1.24M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q4 EPS of $2.32, which includes tax gains and does not compare to the analyst estimate of $1.26. Revenue for the quarter came in at $620.4 million versus the consensus estimate of $619.15 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- Barclays says AI trade is maturing, favors greater diversification
- Circle Internet stock climbs on TD Cowen upgrade, Fed rate hike
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
